Compare CAVA & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAVA | MMSI |
|---|---|---|
| Founded | 2006 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | 2023 | 1990 |
| Metric | CAVA | MMSI |
|---|---|---|
| Price | $48.97 | $86.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 8 |
| Target Price | $79.56 | ★ $105.38 |
| AVG Volume (30 Days) | ★ 5.1M | 707.6K |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 151.16 | N/A |
| EPS | 1.16 | ★ 1.95 |
| Revenue | $1,132,074,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | $24.73 | $13.38 |
| Revenue Next Year | $21.88 | $6.50 |
| P/E Ratio | ★ $42.17 | $44.80 |
| Revenue Growth | ★ 23.93 | 11.41 |
| 52 Week Low | $43.41 | $78.12 |
| 52 Week High | $153.34 | $111.45 |
| Indicator | CAVA | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 53.89 |
| Support Level | $46.26 | $82.70 |
| Resistance Level | $51.15 | $88.57 |
| Average True Range (ATR) | 2.47 | 2.41 |
| MACD | 0.81 | -0.00 |
| Stochastic Oscillator | 72.74 | 68.75 |
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.